The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Associate Professor Sophia Zackrisson, MD, PhD. Photo.

Sophia Zackrisson

Manager

Associate Professor Sophia Zackrisson, MD, PhD. Photo.

ESR Essentials : post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging

Author

  • Elisabetta Giannotti
  • Marcella Pasculli
  • Tamar Sella
  • Chantal Van Ongeval
  • Magda Marcon
  • Mihai Lesaru
  • Julia Camps-Herrero
  • Ritse M. Mann
  • Federica Pediconi
  • Sophia Zackrisson
  • Thiemo Van Nijnatten
  • Isabelle Thomassin-Naggara
  • Francesco Sardanelli
  • Katja Pinker-Domenig
  • Ruud Pijnappel
  • Christiane K. Kuhl
  • Fleur Kilburn-Toppin
  • Thomas Helbich
  • Fiona J. Gilbert
  • Michael Fuchsjäger
  • Gabor Forrai
  • Eva M. Fallenberg
  • Paola Clauser
  • Pascal Baltzer
  • Alexandra Athanasiou
Show all

Summary, in English

Abstract: The breast cancer long-term survival rate has improved; early detection of local recurrence and second primary cancers has been crucial to this success. Mammography is the standard imaging technique for follow-up, but its sensitivity is affected by breast density and post-treatment changes. This article discusses the role of mammography in the follow-up of women after breast cancer treatment, and the use of additional imaging techniques. For patients with genetic mutations or a risk of breast cancer above 20%, high-risk screening protocols are necessary. Non-genetic mutation carriers may require supplemental imaging. Contrast imaging should be offered to women with dense breasts and a young age at diagnosis. While MRI remains the most sensitive tool, it has limitations, and contrast-enhanced mammography (CEM) emerges as a more affordable alternative. Current standards dictate the use of post-operative mammography annual surveillance for at least 5 years. As surveillance strategies evolve, the importance of personalised follow-up based on individual risk factors is emphasised. In fact, there is a need to optimise surveillance protocols and ensure equitable access to appropriate imaging methods for all breast cancer survivors. These recommendations can be implemented into practice by evaluating individual risk factors and engaging patients in shared decision-making. Key Points: Adequate knowledge of normal post-surgical changes of the breast is crucial for avoiding unnecessary work-up. Five-year annual two-view mammography is the standard test for surveillance follow-up. Surveillance follow-up should move beyond a “one size fits all” to a more personalised approach.

Department/s

  • Radiology Diagnostics, Malmö
  • LUCC: Lund University Cancer Centre
  • EpiHealth: Epidemiology for Health
  • LTH Profile Area: Photon Science and Technology
  • LU Profile Area: Light and Materials

Publishing year

2025

Language

English

Publication/Series

European Radiology

Document type

Journal article review

Publisher

Springer Science and Business Media B.V.

Topic

  • Cancer and Oncology

Keywords

  • Breast neoplasm
  • Diagnostic imaging
  • Magnetic resonance imaging
  • Mammography
  • Neoplasm recurrence (local)

Status

Epub

Research group

  • Radiology Diagnostics, Malmö

ISBN/ISSN/Other

  • ISSN: 0938-7994